
Amniocentesis is a prenatal diagnostic test in which a doctor uses a thin needle, guided by ultrasound, to take a small sample of the fluid around your baby. It is usually done between 15 and 20 weeks to check for conditions such as Down's syndrome and thalassaemia. It is offered, not routine, and it carries a small miscarriage risk of about 1 in 200. In India, it can never be used to reveal the baby's sex.
Amniocentesis is a diagnostic test, not a screening test. It gives a near-definite yes or no, unlike the double marker, NIPT or NT scan, which only estimate a chance.
It is offered, not compulsory. It is usually suggested only when a screening test, family history or previous pregnancy points to a higher chance of a specific condition.
The miscarriage risk is about 1 in 200, according to the NHS, and the risk of infection is fewer than 1 in 1,000. Most experienced fetal medicine centres today quote a risk at the lower end of published estimates.
Results for the common chromosomal conditions come in about 3 working days; fuller results can take around 2 weeks.
In India, using amniocentesis to find out the baby's sex is a criminal offence under the PC-PNDT Act. No clinic may legally tell you the sex of the foetus.
Amniocentesis is a test offered during pregnancy to check whether your baby has certain genetic or chromosomal conditions. A doctor uses a thin needle, guided in real time by ultrasound, to draw a small sample of amniotic fluid, the fluid surrounding your baby in the womb. That fluid contains cells shed by the baby, and those cells are analysed in a laboratory (NHS, Amniocentesis).
It is a diagnostic test. This is the single most important thing to understand about it. Screening tests like the double marker test, NIPT and the NT scan estimate the chance that a condition is present. Amniocentesis is different: it examines the baby's own chromosomes and gives a near-definite answer.
Many parents arrive at amniocentesis confused about why they need "another test" after already having blood tests and scans. Here is the difference in one table.
Screening test (double marker, NIPT, NT scan, triple/quadruple marker) | Diagnostic test (amniocentesis, CVS) | |
|---|---|---|
What it tells you | The chance your baby has a condition | A near-definite yes or no |
How it is done | Blood test or ultrasound. Nothing enters the womb | A needle takes a sample from inside the womb |
Risk to pregnancy | None | Small, about 1 in 200 |
Can it be wrong | Yes, it gives false positives and false negatives | Very rarely |
When it is used | Offered to everyone | Offered only when there is a specific reason |
A "high-chance" or "screen positive" result on a screening test does not mean your baby has the condition. It means the chance is high enough that a diagnostic test is worth considering to know for certain. Read Mylo's guide to non-invasive prenatal testing (NIPT) to understand where amniocentesis fits after screening.
Amniocentesis is most commonly used to diagnose chromosomal and genetic conditions, including (NHS; ACOG, Prenatal Genetic Diagnostic Tests):
Down's syndrome (trisomy 21)
Edwards' syndrome (trisomy 18)
Patau's syndrome (trisomy 13)
Thalassaemia and sickle cell disease, both highly relevant in India
Cystic fibrosis
Other inherited single-gene conditions, where a specific family mutation is known
Neural tube defects in some cases, through a marker in the amniotic fluid
It is worth being honest about what it does not do. Amniocentesis is not a general "is my baby healthy" test. It looks for specific conditions the doctor has a reason to check for. It does not detect every possible birth difference, and a normal result does not guarantee a baby with no health issues at all.
For the Indian context, thalassaemia matters enormously. If both parents are carriers, amniocentesis can determine whether the baby is affected. See Mylo's guide to the thalassaemia test during pregnancy.
Amniocentesis is offered, not imposed, and usually only when there is a specific reason to look. You may be offered it if (NHS):
A screening test (double marker, NIPT, NT scan or quadruple marker) has shown a higher chance of a condition
You have had a previous pregnancy or baby affected by one of these conditions
You, your partner, or a close relative carry a genetic condition such as thalassaemia or sickle cell disease
An ultrasound has found a structural difference that needs a chromosomal explanation
Older maternal age on its own is now less often a direct trigger, because screening tests like NIPT usually come first. The decision is always yours to make after counselling. You can decline, and declining is a valid choice.
Amniocentesis is usually performed between 15 and 20 weeks of pregnancy, though it can be done later if needed (NHS). It is not done earlier because before 15 weeks there is less fluid and the miscarriage risk is higher.
If a diagnosis is needed earlier, a different test called chorionic villus sampling (CVS) may be offered instead. CVS is usually done between 11 and 14 weeks and samples the placenta rather than the fluid (NHS, Chorionic villus sampling).
Amniocentesis | CVS | |
|---|---|---|
What is sampled | Amniotic fluid | Placental tissue |
Usual timing | 15 to 20 weeks | 11 to 14 weeks |
Miscarriage risk | About 1 in 200 | Around 1 in 200 for most pregnancies |
Main advantage | Slightly lower technical difficulty, can check neural tube markers | Earlier result, so earlier decisions |
Preparation is simple, and there is usually no fasting required. Practical points:
You do not normally need to fast. You can eat and drink as usual unless your clinic tells you otherwise.
Some clinics ask you to have a moderately full or empty bladder depending on how far along you are. Follow the specific instruction they give you.
Tell your doctor if you are on blood thinners or have a bleeding disorder.
Tell them your blood group. If you are Rh negative, you will be offered an anti-D injection after the procedure (NHS).
Bring someone with you if you can. You are allowed a companion in the room, and having a lift home is sensible.
Ask questions before the day. Genetic counselling before the test is part of good care, not an optional extra.
The procedure itself is quick, usually about 10 minutes (NHS). Knowing the sequence removes a lot of the fear.
You lie down and an ultrasound scan locates the baby, the placenta and a safe pocket of fluid.
Your tummy is cleaned with antiseptic.
A thin needle is passed through your tummy wall into the womb, guided by the ultrasound image the whole time. The needle is deliberately kept away from the baby.
A small sample of amniotic fluid is drawn. This may feel like period-type cramping or pressure. It should be uncomfortable rather than sharply painful.
The needle is removed and the sample is sent to the laboratory.
If you are expecting twins or more, samples may be taken from around each baby.
After the test: mild cramping and a tummy ache in the first day or two are normal, and paracetamol is usually enough. Rest that day and take it easy the next. Most women return to normal activity within a day or two, avoiding heavy lifting and strenuous exercise briefly if advised.
This is the section every parent actually wants, so here it is plainly, with the numbers from the NHS.
Risk | How likely | What to know |
|---|---|---|
Miscarriage | About 1 in 200 pregnancies | Higher with twins or more. Most losses that occur happen within 3 days, occasionally up to 2 weeks after |
Infection | Fewer than 1 in 1,000 procedures | Rare. This is why antiseptic and sterile technique are used |
Needing a repeat | Uncommon | Sometimes not enough fluid is collected the first time |
Leaking fluid or spotting | Uncommon and often settles | Should always be reported to your maternity team |
Passing on an infection to the baby | Only if you carry HIV, hepatitis B or hepatitis C | Tell your doctor. They will discuss how to manage this |
(Source: NHS, Amniocentesis.)
Putting the 1 in 200 in perspective. It means that out of 200 women who have the test, about 199 pregnancies continue unaffected by the procedure. Many modern fetal medicine specialists, using continuous ultrasound guidance, report a risk lower than older figures suggested. The right way to weigh this is with your own doctor, against the reason the test is being offered. The value of a definite answer is different for every family.
For most women it is uncomfortable rather than painful. You may feel a sharp sting as the needle passes the skin, then a cramping or pressure sensation as the fluid is drawn, similar to strong period cramps. It is over quickly. Anaesthetic is not usually needed and is not routinely used, because the injection to numb the skin can be as uncomfortable as the procedure itself. Tell the team if you are anxious about needles; they are used to this and can help you through it.
Rapid results for Down's, Edwards' and Patau's syndromes: around 3 working days (NHS).
Full results, including a complete chromosome analysis or specific genetic tests: around 2 weeks.
The wait is the hardest part for most parents. Ask your clinic exactly which tests are being run and when each result is expected, and how you will be told, by phone or in person.
A normal (negative) result means the specific conditions tested for were not found. It greatly reduces the chance of those conditions, though no test can promise a baby with no health differences of any kind.
An abnormal (positive) result means one of the conditions was found. This is difficult news, and you should not have to process it alone. Your doctor and a genetic counsellor will explain what the specific finding means for your baby, what the range of outcomes is, and what your options are. Those options include continuing the pregnancy with the information and support in place, or, in some cases, considering a termination. This is your decision, and you are entitled to unhurried counselling and support to make it.
Organisations and fetal medicine counsellors exist precisely to help families through this. Ask your hospital what genetic counselling and support they can connect you with.
This is essential context that global sites cannot give you, and it directly affects your appointment.
In India, prenatal diagnostic tests including amniocentesis are governed by the Pre-Conception and Pre-Natal Diagnostic Techniques (Prohibition of Sex Selection) Act, commonly called the PC-PNDT Act (Government of NCT of Delhi, PC-PNDT). What this means in practice:
The test may be used only to detect genetic, chromosomal and certain other medical conditions, not to satisfy curiosity and never for sex selection.
No doctor, laboratory or clinic may tell you the sex of your baby. Communicating the sex of the foetus is a criminal offence, whatever the test. Do not ask your radiologist or obstetrician to reveal it, and be wary of anyone who offers to.
The clinic and laboratory must be registered under the Act. A genuine centre will have its registration displayed.
You will be asked to sign a consent form stating the medical reason for the test. This is normal and lawful.
The law exists to stop female foeticide and the resulting skew in India's sex ratio. Understanding it protects you from unregistered or unlawful clinics and explains why the paperwork around your test is stricter here than in other countries.
Costs vary widely by city, hospital type and the range of genetic tests requested, so any single figure would be misleading. In broad terms, the price usually reflects three things bundled together:
The procedure itself, including the ultrasound guidance and the doctor's time.
The laboratory analysis, which is the largest variable. A rapid chromosomal test costs less than a full karyotype or a specific single-gene study.
Genetic counselling, which good centres include.
In government and medical-college hospitals the cost is substantially lower, and in some cases subsidised, particularly for thalassaemia diagnosis in known carrier couples. Ask for an itemised estimate in writing before the test, and ask specifically which laboratory tests are included, because "amniocentesis" alone does not tell you what analysis you are paying for.
Note for the editorial team: insert current city-wise price bands only if Mylo has verified them. Do not publish an unsourced number.
"My double marker test came back high risk. Does that mean my baby has Down's syndrome?"
No. A high-risk double marker result means the chance is high enough to warrant a closer look, not that the condition is present. Most women with a high-risk screening result go on to have unaffected babies. Your doctor will usually offer either NIPT or a diagnostic test like amniocentesis to find out for certain. Take a breath before you decide anything.
"Is amniocentesis safe? I am terrified about the miscarriage risk."
The risk is real but small, about 1 in 200 by NHS figures, and often lower in experienced fetal medicine centres using continuous ultrasound. The way to think about it is not "risk versus no risk" but "the small risk of the test versus the value of knowing for certain", given your specific situation. That is a conversation to have with your doctor, not a decision to make from a search result.
"Can the doctor tell me my baby's sex during amniocentesis since they are already testing?"
No, and you should not ask. In India, revealing the sex of the foetus is a criminal offence under the PC-PNDT Act, regardless of the test being done. A trustworthy clinic will refuse, and that refusal is a sign they are following the law.
"How many days after amniocentesis should I rest?"
Take it easy on the day of the test and the following day. Mild cramping and a tummy ache in the first day or two are normal, and paracetamol usually helps. Avoid heavy lifting and strenuous exercise briefly. Most women are back to normal within a day or two.
"What are the warning signs I should watch for after the procedure?"
Contact your maternity unit urgently if you have tummy pain that paracetamol does not settle, fluid or bleeding from the vagina, a high temperature, or contractions. These can begin within hours or over the next couple of weeks, so keep your clinic's number handy.
"My screening was normal. Do I still need amniocentesis?"
Usually not. If your screening was low risk and there is no family history or scan finding pointing to a specific condition, amniocentesis is generally not offered, because the small procedure risk is not justified. It is offered when there is a reason, not as a routine check.
"CVS or amniocentesis, which is better?"
Neither is universally better. CVS can be done earlier, around 11 to 14 weeks, so you get answers sooner, which matters if you are weighing decisions. Amniocentesis is done from 15 weeks and can also check certain fluid markers. Both carry a broadly similar small miscarriage risk. Your doctor will recommend one based on how far along you are and what needs testing.
"Is amniocentesis still done, or has NIPT replaced it?"
Both are used, for different jobs. NIPT is a screening blood test with no procedure risk, and it has reduced how often amniocentesis is needed. But NIPT still only estimates a chance. When a definite diagnosis is required, for example to confirm a positive NIPT or to test for thalassaemia in a carrier couple, amniocentesis remains the confirmatory test.
Get urgent medical help after amniocentesis if you have (NHS):
Tummy pain that does not settle with paracetamol, whether constant or coming and going
Fluid leaking from the vagina
Vaginal bleeding
A high temperature, or feeling hot, cold or shivery
Contractions, meaning cramping tummy pain that comes and goes
Call your maternity unit first. If you cannot reach them, contact your doctor urgently.
This article is for information only. It does not replace genetic counselling or the advice of your obstetrician or fetal medicine specialist, who can assess your specific pregnancy and reports.
Amniocentesis is a diagnostic test that gives near-definite answers about specific genetic and chromosomal conditions, which is why it is offered after a screening test raises a concern rather than as a routine check. Its miscarriage risk is small, about 1 in 200, and the decision to have it is always yours to make with proper counselling. In India, remember two things above all: the test can never lawfully be used to reveal your baby's sex, and you are entitled to unhurried support both in deciding whether to have it and in understanding whatever it finds.
All links verified live on 16 September 2026.
Amniocentesis — NHS, UK. Source for the procedure, timing, conditions detected, miscarriage risk (1 in 200), infection risk (fewer than 1 in 1,000), results timelines, anti-D for Rh-negative mothers, and warning signs.
Chorionic villus sampling — NHS, UK. Source for CVS timing, method and miscarriage risk, used in the comparison.
Prenatal Genetic Diagnostic Tests — American College of Obstetricians and Gynecologists. Source for the screening-versus-diagnostic distinction and conditions tested.
Pre-Conception and Pre-Natal Diagnostic Techniques (PC-PNDT) Act — Government of NCT of Delhi (official implementing authority). Source for the Indian legal framework, the prohibition on sex determination, and clinic registration requirements.
This content is for informational purposes only and should not replace professional medical advice. Consult with a physician or other health care professional if you have any concerns or questions about your health. If you rely on the information provided here, you do so solely at your own risk.

Mylo wins Forbes D2C Disruptor award

Mylo wins The Economic Times Promising Brands 2022
Baby Carrier | Baby Soap | Baby Wipes | Stretch Marks Cream | Baby Cream | Baby Shampoo | Baby Massage Oil | Baby Hair Oil | Stretch Marks Oil | Baby Body Wash | Baby Powder | Baby Lotion | Diaper Rash Cream | Newborn Diapers | Teether | Baby Kajal | Baby Diapers Pants | Cloth Diapers | Laundry Detergent | Lactation Granules |